Health Minister Jean-Yves Duclos’ request to suspend consultations on guidelines that would lower the price of pharmaceutical drugs has made it harder for the Patented Medicine Prices Review Board to make decisions going forward, a former board member told MPs Tuesday.
Post a Comment